Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313388083> ?p ?o ?g. }
- W4313388083 endingPage "299" @default.
- W4313388083 startingPage "290" @default.
- W4313388083 abstract "Abstract Patient‐related factors are of prognostic importance in acute myeloid leukemia (AML). Likewise, cardiac disorders may limit the tolerance of intensive therapy. Little is known about the prognostic value of N‐terminal pro‐brain natriuretic peptide (NT‐proBNP). We analyzed NT‐proBNP levels at diagnosis in 312 AML patients (median age: 61 years; range 17–89 years) treated with 3 + 7‐based induction‐chemotherapy and consolidation with up to four cycles of intermediate or high‐dose ARA‐C. NT‐proBNP levels were elevated in 199 patients (63.8%), normal (0–125 pg/ml) in 113 (36.2%), and highly elevated (>2000 pg/ml) in 20 patients (6.4%). Median NT‐proBNP levels differed significantly among patients with complete remission (153.3 pg/ml), no remission (225.9 pg/ml), or early death (735.5 pg/ml) ( p = .002). In multivariate analysis, NT‐proBNP, age, and the 2009 European LeukemiaNet (ELN‐2009) classification were independent predictors of outcome after induction chemotherapy. Overall survival (OS) differed significantly between patients with normal, moderately elevated, and highly elevated NT‐proBNP ( p < .001). These differences were observed in all patients and in patients <60 years but not in those ≥60 years. In multivariate analysis, NT‐proBNP, age, and ELN‐2009 remained independent prognostic variables for OS ( p < .01). Together, NT‐proBNP is an independent prognostic factor indicating the risk of induction failure, early death, and reduced OS in patients with AML." @default.
- W4313388083 created "2023-01-06" @default.
- W4313388083 creator A5001718541 @default.
- W4313388083 creator A5005634785 @default.
- W4313388083 creator A5006306448 @default.
- W4313388083 creator A5026124941 @default.
- W4313388083 creator A5026293305 @default.
- W4313388083 creator A5027660853 @default.
- W4313388083 creator A5034222353 @default.
- W4313388083 creator A5036547515 @default.
- W4313388083 creator A5043288636 @default.
- W4313388083 creator A5050345408 @default.
- W4313388083 creator A5065812269 @default.
- W4313388083 creator A5072208578 @default.
- W4313388083 creator A5072949561 @default.
- W4313388083 creator A5074878867 @default.
- W4313388083 creator A5079506605 @default.
- W4313388083 creator A5080519934 @default.
- W4313388083 date "2023-01-01" @default.
- W4313388083 modified "2023-10-14" @default.
- W4313388083 title "N‐terminal <scp>pro‐brain</scp> natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia" @default.
- W4313388083 cites W1481564836 @default.
- W4313388083 cites W1591796471 @default.
- W4313388083 cites W179444810 @default.
- W4313388083 cites W1965996491 @default.
- W4313388083 cites W1973005031 @default.
- W4313388083 cites W1987771761 @default.
- W4313388083 cites W1988411395 @default.
- W4313388083 cites W2001090115 @default.
- W4313388083 cites W2006919847 @default.
- W4313388083 cites W2043216151 @default.
- W4313388083 cites W2044446185 @default.
- W4313388083 cites W2063166582 @default.
- W4313388083 cites W2085924658 @default.
- W4313388083 cites W2089200614 @default.
- W4313388083 cites W2094087889 @default.
- W4313388083 cites W2097682060 @default.
- W4313388083 cites W2102295251 @default.
- W4313388083 cites W2106512137 @default.
- W4313388083 cites W2111817078 @default.
- W4313388083 cites W2116858301 @default.
- W4313388083 cites W2128812336 @default.
- W4313388083 cites W2136317131 @default.
- W4313388083 cites W2144506100 @default.
- W4313388083 cites W2147646179 @default.
- W4313388083 cites W2154692607 @default.
- W4313388083 cites W2155000917 @default.
- W4313388083 cites W2157973620 @default.
- W4313388083 cites W2171399020 @default.
- W4313388083 cites W2206936864 @default.
- W4313388083 cites W2276580523 @default.
- W4313388083 cites W2318674152 @default.
- W4313388083 cites W2339658711 @default.
- W4313388083 cites W2343944287 @default.
- W4313388083 cites W2427094903 @default.
- W4313388083 cites W2511833681 @default.
- W4313388083 cites W2528197267 @default.
- W4313388083 cites W2551286426 @default.
- W4313388083 cites W2577156677 @default.
- W4313388083 cites W2734477894 @default.
- W4313388083 cites W2735293835 @default.
- W4313388083 cites W2751152093 @default.
- W4313388083 cites W2761856325 @default.
- W4313388083 cites W2793948874 @default.
- W4313388083 cites W2904314282 @default.
- W4313388083 cites W2951640140 @default.
- W4313388083 cites W2965273658 @default.
- W4313388083 cites W3037780771 @default.
- W4313388083 cites W4225857376 @default.
- W4313388083 cites W4285719527 @default.
- W4313388083 cites W4313388083 @default.
- W4313388083 doi "https://doi.org/10.1002/ajh.26805" @default.
- W4313388083 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36588398" @default.
- W4313388083 hasPublicationYear "2023" @default.
- W4313388083 type Work @default.
- W4313388083 citedByCount "3" @default.
- W4313388083 countsByYear W43133880832023 @default.
- W4313388083 crossrefType "journal-article" @default.
- W4313388083 hasAuthorship W4313388083A5001718541 @default.
- W4313388083 hasAuthorship W4313388083A5005634785 @default.
- W4313388083 hasAuthorship W4313388083A5006306448 @default.
- W4313388083 hasAuthorship W4313388083A5026124941 @default.
- W4313388083 hasAuthorship W4313388083A5026293305 @default.
- W4313388083 hasAuthorship W4313388083A5027660853 @default.
- W4313388083 hasAuthorship W4313388083A5034222353 @default.
- W4313388083 hasAuthorship W4313388083A5036547515 @default.
- W4313388083 hasAuthorship W4313388083A5043288636 @default.
- W4313388083 hasAuthorship W4313388083A5050345408 @default.
- W4313388083 hasAuthorship W4313388083A5065812269 @default.
- W4313388083 hasAuthorship W4313388083A5072208578 @default.
- W4313388083 hasAuthorship W4313388083A5072949561 @default.
- W4313388083 hasAuthorship W4313388083A5074878867 @default.
- W4313388083 hasAuthorship W4313388083A5079506605 @default.
- W4313388083 hasAuthorship W4313388083A5080519934 @default.
- W4313388083 hasBestOaLocation W43133880831 @default.
- W4313388083 hasConcept C126322002 @default.
- W4313388083 hasConcept C143998085 @default.
- W4313388083 hasConcept C2775846464 @default.